More encouragingly, combination treatment with V‐9302 and an anti‐PD‐1 antibody exhibited a superior effect in controlling tumor growth and prolonging the survival in tumor‐bearing mice compared to either monotherapy alone (Figure 8C). The gene discussed is PDCD1; the disease is neoplasm.